
Clinical Trials - Rare Diseases
Rare Disease Clinical Trials in Pediatric Populations: Lessons Learned
|
-
Traci Fulton
has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778849, hs_child_table_id=0, hs_updated_at=1714461239390, hs_published_at=1744844126301, description=Traci Fulton is Vice President of Project Management at Precision for Medicine, providing senior level oversight and support for clinical trials spanning rare disease, oncology and CNS indications. Ms. Fulton brings over 21 years’ experience with CRO teams, supporting the conduct of clinical trials across all phases, with over 18 years of her career focused on execution and delivery for complex clinical trials in oncology and rare diseases. She is passionate in her approach to support trials and her drive to support advancements in the treatment for underserved patient populations., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Traci%20Fulton.webp',altText='Traci Fulton',fileId=165892782093}, linkedin=https://www.linkedin.com/in/traci-kruckemyer-fulton-70ab42a, hs_name=, hs_path=, lastname=Fulton, hs_initial_published_at=1716212769184, hs_created_at=1709645745080, hs_is_edited=false, hs_deleted_at=0, name=Traci, job=, slug=traci-fulton, email=, hs_updated_by_user_id=51739740}, second={}, third={}})